Identification and characterization of Runx2 phosphorylation sites involved in matrix metalloproteinase-13 promoter activation

FEBS Letters

Volumn 583, Issue 7, 2009, Pages 1141-1146

  Selvamurugan, Nagarajan ^a   Shimizu, Emi ^b   Lee, Minnkyong ^b   Liu, Tong ^c   Li, Hong ^c   Partridge, Nicola C ^b  

^a UNIVERSITY OF MADRAS   (India)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Collagenase 3; Cyclic adenosine mono phosphate; Matrix metalloproteinase 13; Parathyroid hormone; Runx2

Indexed keywords

8 BROMO CYCLIC AMP; COLLAGENASE 3; CYCLIC AMP DEPENDENT PROTEIN KINASE; THREONINE; TRANSCRIPTION FACTOR RUNX2;

ANIMAL CELL; ARTICLE; BONE REMODELING; CONTROLLED STUDY; ENZYME ACTIVATION; IN VITRO STUDY; NONHUMAN; OSTEOBLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; WILD TYPE;

8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ANIMALS; BONE REMODELING; CERCOPITHECUS AETHIOPS; CORE BINDING FACTOR ALPHA 1 SUBUNIT; COS CELLS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENZYME INDUCTION; MATRIX METALLOPROTEINASE 13; MICE; MUTATION; PARATHYROID HORMONE; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; TRANSCRIPTIONAL ACTIVATION;

RATTUS;

EID: 62849108358     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2009.02.040     Document Type: Article

References (30)

1. Yasuda H., Shima N., Nakagawa N., Yamaguchi K., Kinosaki M., Mochizuki S., Tomoyasu A., Yano K., Goto M., Murakami A., Tsuda E., Morinaga T., Higashio K., Udagawa N., Takahashi N., and Suda T. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc. Natl. Acad. Sci. USA 95 (1998) 3597-3602
2. Partridge N.C., Jeffrey J.J., Ehlich L.S., Teitelbaum S.L., Fliszar C., Welgus H.G., and Kahn A.J. Hormonal regulation of the production of collagenase and a collagenase inhibitor activity by rat osteogenic sarcoma cells. Endocrinology 120 (1987) 1956-1962
3. Witty J.P., Foster S.A., Stricklin G.P., Matrisian L.M., and Stern P.H. Parathyroid hormone-induced resorption in fetal rat limb bones is associated with production of the metalloproteinases collagenase and gelatinase B. J. Bone Miner. Res. 11 (1996) 72-78
4. Delaisse J.M., Eeckhout Y., and Vaes G. Bone-resorbing agents affect the production and distribution of procollagenase as well as the activity of collagenase in bone tissue. Endocrinology 123 (1988) 264-276
5. Zhao W., Byrne M.H., Boyce B.F., and Krane S.M. Bone resorption induced by parathyroid hormone is strikingly diminished in collagenase-resistant mutant mice. J. Clin. Invest. 103 (1999) 517-524
6. Inada M., Wang Y., Byrne M.H., Rahman M.U., Miyaura C., Lopez-Otin C., and Krane S.M. Critical roles for collagenase-3 (Mmp13) in development of growth plate cartilage and in endochondral ossification. Proc. Natl. Acad. Sci. USA 101 (2004) 17192-17197
7. Scott D.K., Brakenhoff K.D., Clohisy J.C., Quinn C.O., and Partridge N.C. Parathyroid hormone induces transcription of collagenase in rat osteoblastic cells by a mechanism using cyclic adenosine 3′,5′-monophosphate and requiring protein synthesis. Mol. Endocrinol. 6 (1992) 2153-2159
8. Selvamurugan N., Pulumati M.R., Tyson D.R., and Partridge N.C. Parathyroid hormone regulation of the rat collagenase-3 promoter by protein kinase A-dependent transactivation of core binding factor alpha1. J. Biol. Chem. 275 (2000) 5037-5042
9. Selvamurugan N., Chou W.Y., Pearman A.T., Pulumati M.R., and Partridge N.C. Parathyroid hormone regulates the rat collagenase-3 promoter in osteoblastic cells through the cooperative interaction of the activator protein-1 site and the runt domain binding sequence. J. Biol. Chem. 273 (1998) 10647-10657
10. Komori T., Yagi H., Nomura S., Yamaguchi A., Sasaki K., Deguchi K., Shimizu Y., Bronson R.T., Gao Y.H., Inada M., Sato M., Okamoto R., Kitamura Y., Yoshiki S., and Kishimoto T. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89 (1997) 755-764
11. Otto F., Thornell A.P., Crompton T., Denzel A., Gilmour K.C., Rosewell I.R., Stamp G.W., Beddington R.S., Mundlos S., Olsen B.R., Selby P.B., and Owen M.J. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89 (1997) 765-771
12. Ducy P., Zhang R., Geoffroy V., Ridall A.L., and Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89 (1997) 747-754
13. Banerjee C., McCabe L.R., Choi J.Y., Hiebert S.W., Stein J.L., Stein G.S., and Lian J.B. Runt homology domain proteins in osteoblast differentiation: AML3/CBFA1 is a major component of a bone-specific complex. J. Cell Biochem. 66 (1997) 1-8
14. Lian J.B., Javed A., Zaidi S.K., Lengner C., Montecino M., van Wijnen A.J., Stein J.L., and Stein G.S. Regulatory controls for osteoblast growth and differentiation: role of Runx/Cbfa/AML factors. Crit. Rev. Eukar. Gene Exp. 14 (2004) 1-41
15. Selvamurugan N., Jefcoat S.C., Kwok S., Kowalewski R., Tamasi J.A., and Partridge N.C. Overexpression of Runx2 directed by the matrix metalloproteinase-13 promoter containing the AP-1 and Runx/RD/Cbfa sites alters bone remodeling in vivo. J. Cell Biochem. 99 (2006) 545-557
16. Coffman J.A. Runx transcription factors and the developmental balance between cell proliferation and differentiation. Cell Biol. Int. 27 (2003) 315-324
17. Westendorf J.J., and Hiebert S.W. Mammalian runt-domain proteins and their roles in hematopoiesis, osteogenesis, and leukemia. J. Cell Biochem Suppl. (1999) 51-58
18. Javed A., Barnes G.L., Pratap J., Antkowiak T., Gerstenfeld L.C., van Wijnen A.J., Stein J.L., Lian J.B., and Stein G.S. Impaired intranuclear trafficking of Runx2 (AML3/CBFA1) transcription factors in breast cancer cells inhibits osteolysis in vivo. Proc. Natl. Acad. Sci. USA 102 (2005) 1454-1459
19. Namchuk M., Lindsay L., Turck C.W., Kanaani J., and Baekkeskov S. Phosphorylation of serine residues 3, 6, 10, and 13 distinguishes membrane anchored from soluble glutamic acid decarboxylase 65 and is restricted to glutamic acid decarboxylase 65alpha. J. Biol. Chem. 272 (1997) 1548-1557
20. Tanaka T., Kurokawa M., Ueki K., Tanaka K., Imai Y., Mitani K., Okazaki K., Sagata N., Yazaki Y., Shibata Y., Kadowaki T., and Hirai H. The extracellular signal-regulated kinase pathway phosphorylates AML1, an acute myeloid leukemia gene product, and potentially regulates its transactivation ability. Mol. Cell Biol. 16 (1996) 3967-3979
21. Tintut Y., Parhami F., Le V., Karsenty G., and Demer L.L. Inhibition of osteoblast-specific transcription factor Cbfa1 by the cAMP pathway in osteoblastic cells. Ubiquitin/proteasome-dependent regulation. J. Biol. Chem. 274 (1999) 28875-28879
22. Huang G., Shigesada K., Ito K., Wee H.J., Yokomizo T., and Ito Y. Dimerization with PEBP2beta protects RUNX1/AML1 from ubiquitin-proteasome-mediated degradation. EMBO J. 20 (2001) 723-733
23. Krishnan V., Moore T.L., Ma Y.L., Helvering L.M., Frolik C.A., Valasek K.M., Ducy P., and Geiser A.G. Parathyroid hormone bone anabolic action requires Cbfa1/Runx2-dependent signaling. Mol. Endocrinol. 17 (2003) 423-435
24. Shui C., Spelsberg T.C., Riggs B.L., and Khosla S. Changes in Runx2/Cbfa1 expression and activity during osteoblastic differentiation of human bone marrow stromal cells. J. Bone Miner. Res. 18 (2003) 213-221
25. Selvamurugan N., Kwok S., Alliston T., Reiss M., and Partridge N.C. Transforming growth factor-beta 1 regulation of collagenase-3 expression in osteoblastic cells by cross-talk between the Smad and MAPK signaling pathways and their components, Smad2 and Runx2. J. Biol. Chem. 279 (2004) 19327-19334
26. Bokui N., Otani T., Igarashi K., Kaku J., Oda M., Nagaoka T., Seno M., Tatematsu K., Okajima T., Matsuzaki T., Ting K., Tanizawa K., and Kuroda S. Involvement of MAPK signaling molecules and Runx2 in the NELL1-induced osteoblastic differentiation. FEBS Lett. 582 (2008) 365-371
27. Franceschi R.T., Xiao G., Jiang D., Gopalakrishnan R., Yang S., and Reith E. Multiple signaling pathways converge on the Cbfa1/Runx2 transcription factor to regulate osteoblast differentiation. Conn. Tissue Res. 44 (2003) 109-116
28. Wee H.J., Huang G., Shigesada K., and Ito Y. Serine phosphorylation of RUNX2 with novel potential functions as negative regulatory mechanisms. EMBO Rep. 3 (2002) 967-974
29. Phillips J.E., Gersbach C.A., Wojtowicz A.M., and Garcia A.J. Glucocorticoid-induced osteogenesis is negatively regulated by Runx2/Cbfa1 serine phosphorylation. J. Cell. Sci. 119 (2006) 581-591
30. Ge C., Xiao G., Jiang D., and Franceschi R.T. Critical role of the extracellular signal-regulated kinase-MAPK pathway in osteoblast differentiation and skeletal development. J. Cell. Biol. 176 (2007) 709-718